Stock Split History
ETFs Holding RXRX »    RXRX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG. According to our Recursion Pharmaceuticals stock split history records, Recursion Pharmaceuticals has had 0 splits.
Recursion Pharmaceuticals stock split history picture
Recursion Pharmaceuticals (RXRX) has 0 splits in our Recursion Pharmaceuticals stock split history database.

Looking at the Recursion Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Recursion Pharmaceuticals shares, starting with a $10,000 purchase of RXRX, presented on a split-history-adjusted basis factoring in the complete Recursion Pharmaceuticals stock split history. Recursion Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/19/2021
End date: 05/26/2023
Start price/share: $28.00
End price/share: $8.93
Dividends collected/share: $0.00
Total return: -68.11%
Average Annual Total Return: -41.95%
Starting investment: $10,000.00
Ending investment: $3,189.05
Years: 2.10
Date Ratio
Lordstown Motors Corp. (RIDE)
Evolve Transition Infrastructure LP (SNMP)
SeaChange International, Inc. (SEAC)
Sigilon Therapeutics, Inc. (SGTX)
TransCode Therapeutics, Inc. (RNAZ)
Adamis Pharmaceuticals Corporation (ADMP)
Nisun International Enterprise Development Group Co., Ltd (NISN)
Cyclerion Therapeutics, Inc. (CYCN)
Greenidge Generation Holdings Inc. (GREE)
Stronghold Digital Mining, Inc. (SDIG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Recursion Pharmaceuticals
Recursion Pharmaceuticals Insider Buying

Recursion Pharmaceuticals Stock Split History | | Copyright © 2013 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.